In conclusion, this study delineated that TAC has a potential effect on the amelioration of tubuloinflammation and fibrosis, partially through NFATc1/TRPC6 (Figure 8), which provides more evidence for the renoprotective effects of TAC under hyperglycaemia. Here, TRPC6 is linked to Hyperglycemia.